A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activity.
journal contributionposted on 2021-10-13, 09:33 authored by Darren GriffithDarren Griffith, Maria MorganMaria Morgan, Celine MarmionCeline Marmion
The successful design and synthesis of a novel multifunctional platinum drug candidate with DNA binding, histone deacetylase inhibitory activity and enhanced selectivity for cancer cells are described.
CommentsThis article is also available from http://pubs.rsc.org
Published CitationGriffith D, Morgan MP, Marmion CJ. A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activity. Chem Commun (Camb). 2009;44:6735-6737
- School of Pharmacy and Biomolecular Sciences